Histopathology10.1111/his.120692013625723-730Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapyChangzheng Du, Jun Zhao, Weicheng Xue, Fangyuan Dou, Jin Gu
European Journal of Cancer10.1016/s0959-8049(99)00045-31999356942-945Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancerM. Nilbert, M. Planck, E. Fernebro, Å. Borg, A. Johnson,
Radiotherapy and Oncology10.1016/s0167-8140(16)31360-32016119S51SP-0111: Response prediction in rectal cancer using PET RadiomicsR.T.H. Leijenaar, P. Lambin,
Radiotherapy and Oncology10.1016/s0167-8140(17)32218-12017123S920EP-1686: Diffusion weighted imaging for treatment response prediction in advanced rectal cancerH.D. Nissen,
Radiotherapy and Oncology10.1016/s0167-8140(01)80490-4200158S94350 poster Microsatellite instability associated with primary head and neck cancers and secondary esophageal cancers,
European Journal of Cancer10.1016/j.ejca.2011.10.00520124881235-1243The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancerSung Pil Hong, Byung So Min, Tae Il Kim, Jae Hee Cheon, Nam Kyu Kim, Hoguen Kim, Won Ho Kim,
Radiotherapy and Oncology10.1016/s0167-8140(12)73065-7200992S181INTERFRACTION RECTAL MOTION DURING RADIOTHERAPY FOR RECTAL CANCERB. van Asselen, B. Raaymakers, O. Reerink,
Radiotherapy and Oncology10.1016/s0167-8140(04)80613-3200472S34-S35113 Change in rectal volume during prostate cancer radiotherapy : impact on rectal DVH,
European Journal of Cancer10.1016/j.ejca.2020.04.046202013575-77Pathological complete response after neoadjuvant immunotherapy for a patient with microsatellite instability locally advanced rectal cancer: should we adapt our standard management for these patients?L. Mans, M. Pezzullo, N. D'Haene, J. Van de Stadt, J.-L. Van Laethem,
Radiotherapy and Oncology10.1016/s0167-8140(02)83453-3200265S729 Preoperative radiotherapy with concurrent protracted venous infusional 5-fluorouracil for rectal cancer — Toxicity andpathological response from three dose levels,